Legal & General Group PLC Arcturus Therapeutics Holdings Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 26,255 shares of ARCT stock, worth $420,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,255

Previous 26,255 -0.0%

Holding current value

$420,605

Previous $609,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $14,879 - $20,887	823 Added 3.24%	26,255 $609,000
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $89,778 - $163,665	3,687 Added 16.96%	25,432 $619,000
Q1 2024 May 14, 2024	BUY	$31.23 - $42.99 $22,860 - $31,468	732 Added 3.48%	21,745 $734,000
Q4 2023 Feb 15, 2024	BUY	$17.71 - $32.97 $12,060 - $22,452	681 Added 3.35%	21,013 $662,000
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $712 - $1,045	-28 Reduced 0.14%	20,332 $519,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $251,370 - $339,780	10,500 Added 106.49%	20,360 $583,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $7,124 - $11,601	484 Added 5.16%	9,860 $236,000
Q4 2022 Feb 14, 2023	BUY	$14.14 - $23.06 $7,282 - $11,875	515 Added 5.81%	9,376 $159,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $65,380 - $110,871	-5,010 Reduced 36.12%	8,861 $131,000
Q2 2022 Aug 22, 2022	BUY	$12.26 - $31.17 $15,999 - $40,676	1,305 Added 10.39%	13,871 $218,000
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $102,087 - $141,966	2,985 Added 31.16%	12,566 $465,000
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $115,841 - $242,028	4,155 Added 76.58%	9,581 $457,000
Q2 2021 Aug 12, 2021	SELL	$25.79 - $42.11 $14,339 - $23,413	-556 Reduced 9.29%	5,426 $184,000
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $2,441 - $5,475	-63 Reduced 1.04%	5,982 $247,000
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $23,811 - $85,078	688 Added 12.84%	6,045 $262,000
Q3 2020 Nov 13, 2020	SELL	$37.49 - $63.19 $8,772 - $14,786	-234 Reduced 4.19%	5,357 $229,000
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $70,782 - $325,787	5,591 New	5,591 $262,000

Others Institutions Holding ARCT

# of Institutions

180

Shares Held

25.7M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $426M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Arcturus Therapeutics Holdings Inc. Transaction History